| ADM | admission |
| ACE2 | angiotensin-converting enzyme 2 |
| BP | blood pressure |
| CVD | cardiovascular disease |
| COVID-19 | coronavirus disease 2019 |
| DBP | diastolic blood pressure |
| DPP-4 | dipeptidyl peptidase-4 inhibitor |
| ED | emergency department |
| GIH | glucocorticoid-induced hyperglycaemia |
| GLP-1 | glucagon-like peptide 1 |
| HDL-C | high-density lipoprotein cholesterol |
| LDL-C | low-density lipoprotein cholesterol |
| Long-COVID | long-coronavirus disease |
| n | sample size |
| NADPH | reduced nicotinamide adenine dinucleotide phosphate |
| p | p-value |
| post-COVID | post-coronavirus disease |
| PTMs | post-translational protein modifications |
| RAAS | renin-angiotensin-aldosterone system |
| ROS | reactive oxygen species (ROS) |
| RT-PCR | real-time reverse-transcriptase polymerase chain reaction |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| SD | standard deviation |
| SETDB2 | SET Domain Bifurcated Histone Lysine Methyltransferase 2 |
| SBP | systolic blood pressure |
| VLDL-C | very low-density lipoprotein cholesterol |